Biotechnology
The Biotechnology industry has a total of 598 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.38 billion.
Market Cap
1.11T
Revenue
105.38B
Profits
-41.4B
PE Ratio
n/a
Profit Margin
-39.28%
Dividend Yield
0.04%
598 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 119.61B | -0.89% | 511,931 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.85B | -1.36% | 826,834 | 14.34B |
| 3 | ARGX | argenx SE | 51.17B | -0.55% | 220,604 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 44.69B | -2.45% | 1,013,489 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.66B | -2.75% | 201,753 | 4.97B |
| 6 | INSM | Insmed Incorporated | 33.43B | -0.67% | 1,800,833 | 447.02M |
| 7 | BNTX | BioNTech SE | 28.64B | -2.26% | 563,374 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 24.00B | 1.76% | 2,021,931 | 2.35B |
| 9 | GMAB | Genmab A/S | 19.81B | -2.52% | 1,164,708 | 3.85B |
| 10 | INCY | Incyte Corporation | 19.64B | -1.01% | 925,997 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 18.70B | -1.47% | 1,122,226 | - |
| 12 | MRNA | Moderna, Inc. | 17.07B | -6.80% | 7,827,143 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 15.04B | -1.77% | 1,553,806 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.92B | -2.13% | 1,477,126 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 13.88B | 0.97% | 202,601 | 758.59M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.42B | -1.25% | 1,413,556 | 966.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 11.31B | -4.74% | 2,903,745 | - |
| 18 | EXEL | Exelixis, Inc. | 11.18B | -1.80% | 2,042,820 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.10B | -1.17% | 150,485 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.94B | 0.06% | 836,205 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.82B | -1.21% | 1,087,433 | 3.09B |
| 22 | TECH | Bio-Techne Corporation | 9.99B | 0.17% | 1,645,935 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 9.99B | 0.21% | 828,584 | 4.16B |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.84B | 1.72% | 1,953,142 | 829.45M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 9.34B | -0.01% | 234,135 | 561.26M |
| 26 | ABVX | ABIVAX Société Anonyme | 8.91B | -1.29% | 491,597 | 6.23M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.71B | -0.09% | 463,980 | 7.46M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.45B | -2.00% | 966,166 | 1.24B |
| 29 | KRYS | Krystal Biotech, Inc. | 8.17B | 0.83% | 131,198 | 373.16M |
| 30 | NUVL | Nuvalent, Inc. | 8.02B | 0.88% | 324,410 | - |
| 31 | CYTK | Cytokinetics, Incorporated | 7.75B | -3.41% | 1,159,691 | 87.21M |
| 32 | PCVX | Vaxcyte, Inc. | 7.13B | 3.07% | 3,854,887 | - |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.84B | -1.22% | 396,851 | 174.33M |
| 34 | CAI | Caris Life Sciences, Inc. | 6.61B | -7.02% | 2,103,189 | 649.06M |
| 35 | BLTE | Belite Bio, Inc | 6.23B | -1.73% | 152,086 | - |
| 36 | IBRX | ImmunityBio, Inc. | 6.15B | 5.58% | 24,703,381 | 82.56M |
| 37 | MIRM | Mirum Pharmaceuticals, Inc. | 6.13B | -0.48% | 413,223 | 471.79M |
| 38 | GPCR | Structure Therapeutics Inc. | 6.10B | 1.17% | 666,225 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 6.05B | -1.47% | 544,570 | 1.78B |
| 40 | KYMR | Kymera Therapeutics, Inc. | 5.77B | -2.44% | 567,288 | 43.74M |
| 41 | COGT | Cogent Biosciences, Inc. | 5.47B | -4.44% | 992,287 | - |
| 42 | IMVT | Immunovant, Inc. | 5.28B | -1.47% | 1,252,175 | - |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 5.11B | 2.61% | 789,577 | 209.22M |
| 44 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.11B | -3.93% | 725,820 | 1.54M |
| 45 | CELC | Celcuity Inc. | 5.04B | -2.83% | 373,127 | - |
| 46 | CRSP | CRISPR Therapeutics AG | 4.75B | -6.49% | 1,624,297 | 38.34M |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.52B | -1.31% | 528,244 | - |
| 48 | APGE | Apogee Therapeutics, Inc. | 4.51B | -4.52% | 1,568,450 | - |
| 49 | FOLD | Amicus Therapeutics, Inc. | 4.42B | 0.11% | 3,098,830 | 598.70M |
| 50 | TGTX | TG Therapeutics, Inc. | 4.33B | -1.33% | 882,882 | 531.90M |
| 51 | ACAD | ACADIA Pharmaceuticals Inc. | 4.27B | -1.91% | 627,800 | 1.05B |
| 52 | CORT | Corcept Therapeutics Incorporated | 4.20B | -10.49% | 3,776,059 | 741.17M |
| 53 | CGON | CG Oncology, Inc. | 4.17B | -3.33% | 489,751 | 2.17M |
| 54 | ADMA | ADMA Biologics, Inc. | 4.13B | 2.06% | 2,142,699 | 488.56M |
| 55 | ACLX | Arcellx, Inc. | 3.97B | 0.48% | 441,907 | 35.90M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 3.76B | -2.00% | 100,709 | 251.23M |
| 57 | TERN | Terns Pharmaceuticals, Inc. | 3.75B | 0.86% | 2,214,641 | - |
| 58 | LQDA | Liquidia Corporation | 3.72B | -0.72% | 1,071,790 | 69.22M |
| 59 | CNTA | Centessa Pharmaceuticals plc | 3.59B | -1.33% | 708,896 | 15.00M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.54B | -0.67% | 170,368 | 35.24M |
| 61 | DNLI | Denali Therapeutics Inc. | 3.38B | 0.37% | 1,997,145 | - |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.33B | -2.65% | 2,769,833 | - |
| 63 | ERAS | Erasca, Inc. | 3.22B | 0.78% | 3,453,711 | - |
| 64 | LEGN | Legend Biotech Corporation | 3.20B | -2.14% | 2,112,263 | 909.05M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.16B | -2.11% | 316,894 | 7.50M |
| 66 | VRDN | Viridian Therapeutics, Inc. | 3.16B | -1.52% | 1,680,083 | 70.79M |
| 67 | ARQT | Arcutis Biotherapeutics, Inc. | 3.11B | -1.40% | 534,943 | 317.93M |
| 68 | ALMS | Alumis Inc. | 3.10B | -7.38% | 1,076,325 | 22.12M |
| 69 | VERA | Vera Therapeutics, Inc. | 3.09B | -3.31% | 770,872 | - |
| 70 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.01B | -0.51% | 493,902 | 578.20M |
| 71 | EWTX | Edgewise Therapeutics, Inc. | 2.99B | -1.81% | 595,937 | - |
| 72 | IRON | Disc Medicine, Inc. | 2.94B | -0.81% | 274,874 | - |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.92B | -0.89% | 1,721,811 | - |
| 74 | APLS | Apellis Pharmaceuticals, Inc. | 2.84B | -2.65% | 2,471,793 | 1.02B |
| 75 | ADPT | Adaptive Biotechnologies Corporation | 2.82B | 0.49% | 1,166,656 | 252.75M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.82B | -2.64% | 504,437 | 214.83M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.78B | -2.72% | 1,196,434 | 435.83M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.76B | -4.68% | 1,123,601 | 55.70M |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.74B | -1.84% | 295,447 | 366.10M |
| 80 | IMNM | Immunome, Inc. | 2.74B | -1.04% | 936,205 | 9.68M |
| 81 | RCUS | Arcus Biosciences, Inc. | 2.61B | -3.17% | 749,307 | 240.00M |
| 82 | SYRE | Spyre Therapeutics, Inc. | 2.51B | -3.66% | 314,284 | - |
| 83 | TLX | Telix Pharmaceuticals Limited | 2.50B | -6.13% | 110,610 | 664.23M |
| 84 | MLYS | Mineralys Therapeutics, Inc. | 2.45B | -3.40% | 576,937 | - |
| 85 | WVE | Wave Life Sciences Ltd. | 2.38B | 0.08% | 1,359,408 | 109.23M |
| 86 | RARE | Ultragenyx Pharmaceutical Inc. | 2.31B | -1.17% | 2,264,562 | 630.60M |
| 87 | DNTH | Dianthus Therapeutics, Inc. | 2.29B | -0.04% | 2,531,377 | 3.08M |
| 88 | MESO | Mesoblast Limited | 2.29B | -3.56% | 205,036 | 17.20M |
| 89 | AAPG | Ascentage Pharma Group International | 2.27B | -2.40% | 8,500 | 54.52M |
| 90 | GLPG | Galapagos NV | 2.23B | -0.85% | 81,811 | 336.64M |
| 91 | RXRX | Recursion Pharmaceuticals, Inc. | 2.17B | -3.36% | 15,716,833 | 43.69M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.14B | -4.03% | 1,902,131 | 2.41B |
| 93 | MAZE | Maze Therapeutics, Inc. | 2.12B | -2.22% | 367,097 | 2.50M |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 2.11B | -0.65% | 224,999 | 825.94M |
| 95 | SLNO | Soleno Therapeutics, Inc. | 2.08B | -4.39% | 1,598,222 | 98.68M |
| 96 | OLMA | Olema Pharmaceuticals, Inc. | 1.99B | -2.72% | 782,713 | - |
| 97 | OCUL | Ocular Therapeutix, Inc. | 1.95B | -8.24% | 5,492,588 | 55.78M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.92B | -0.34% | 406,914 | 265.81M |
| 99 | SION | Sionna Therapeutics, Inc. | 1.89B | -0.07% | 156,732 | - |
| 100 | ARDX | Ardelyx, Inc. | 1.88B | -1.53% | 1,815,539 | 398.23M |
| 101 | VCEL | Vericel Corporation | 1.84B | -0.33% | 228,327 | 258.72M |
| 102 | ZLAB | Zai Lab Limited | 1.84B | -4.12% | 370,847 | 441.63M |
| 103 | NUVB | Nuvation Bio Inc. | 1.79B | -2.06% | 2,945,746 | 26.75M |
| 104 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | -0.78% | 1,570,647 | 111.30M |
| 105 | MNKD | MannKind Corporation | 1.76B | -0.86% | 2,871,531 | 313.79M |
| 106 | PHVS | Pharvaris N.V. | 1.75B | -3.02% | 66,635 | - |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.74B | -1.67% | 269,930 | 205.63M |
| 108 | CRVS | Corvus Pharmaceuticals, Inc. | 1.71B | -2.39% | 1,799,966 | - |
| 109 | NRIX | Nurix Therapeutics, Inc. | 1.70B | -6.08% | 1,076,598 | 83.98M |
| 110 | ZYME | Zymeworks Inc. | 1.69B | 0.76% | 371,244 | 134.48M |
| 111 | MBX | MBX Biosciences, Inc. | 1.67B | 1.02% | 725,880 | - |
| 112 | RAPT | RAPT Therapeutics, Inc. | 1.67B | 0.10% | 1,819,314 | - |
| 113 | UPB | Upstream Bio, Inc. | 1.67B | -0.13% | 448,979 | 2.80M |
| 114 | DFTX | Definium Therapeutics, Inc. | 1.66B | -2.20% | 1,085,783 | - |
| 115 | ORKA | Oruka Therapeutics, Inc. | 1.66B | -2.92% | 275,086 | - |
| 116 | IMCR | Immunocore Holdings plc | 1.65B | -0.94% | 652,002 | 379.59M |
| 117 | CLDX | Celldex Therapeutics, Inc. | 1.64B | 0.24% | 298,316 | 2.60M |
| 118 | TYRA | Tyra Biosciences, Inc. | 1.63B | -5.41% | 676,169 | - |
| 119 | OCS | Oculis Holding AG | 1.63B | -0.09% | 402,571 | 992.00K |
| 120 | GLUE | Monte Rosa Therapeutics, Inc. | 1.62B | -4.17% | 1,080,886 | 181.54M |
| 121 | AGIO | Agios Pharmaceuticals, Inc. | 1.60B | -0.72% | 267,077 | 44.79M |
| 122 | PGEN | Precigen, Inc. | 1.59B | -1.10% | 2,083,610 | 6.31M |
| 123 | ELVN | Enliven Therapeutics, Inc. | 1.58B | 3.54% | 1,331,576 | - |
| 124 | BHVN | Biohaven Ltd. | 1.57B | -2.40% | 1,057,028 | - |
| 125 | TNGX | Tango Therapeutics, Inc. | 1.55B | -1.20% | 836,650 | 66.50M |
| 126 | FTRE | Fortrea Holdings Inc. | 1.55B | -1.88% | 462,884 | 2.76B |
| 127 | NTLA | Intellia Therapeutics, Inc. | 1.52B | -5.79% | 4,168,743 | 57.53M |
| 128 | INVA | Innoviva, Inc. | 1.50B | 1.77% | 315,693 | 388.52M |
| 129 | KOD | Kodiak Sciences Inc. | 1.43B | -9.48% | 765,061 | - |
| 130 | NVAX | Novavax, Inc. | 1.41B | -8.10% | 3,901,808 | 1.06B |
| 131 | QURE | uniQure N.V. | 1.41B | -4.54% | 1,009,679 | 15.75M |
| 132 | PHAR | Pharming Group N.V. | 1.39B | -2.37% | 27,063 | 362.27M |
| 133 | TRVI | Trevi Therapeutics, Inc. | 1.37B | -0.37% | 775,107 | - |
| 134 | ATAI | AtaiBeckley Inc. | 1.36B | -2.34% | 1,569,846 | 3.02M |
| 135 | DBVT | DBV Technologies S.A. | 1.33B | -5.92% | 313,860 | 5.50M |
| 136 | RLAY | Relay Therapeutics, Inc. | 1.33B | -0.78% | 507,547 | 8.36M |
| 137 | SVRA | Savara Inc. | 1.30B | -3.76% | 749,338 | - |
| 138 | ANAB | AnaptysBio, Inc. | 1.30B | -2.22% | 299,794 | 169.47M |
| 139 | IMTX | Immatics N.V. | 1.28B | 2.13% | 454,911 | 99.45M |
| 140 | RAPP | Rapport Therapeutics, Inc. | 1.27B | -0.56% | 206,438 | - |
| 141 | TSHA | Taysha Gene Therapies, Inc. | 1.24B | -1.09% | 1,219,409 | 6.31M |
| 142 | XERS | Xeris Biopharma Holdings, Inc. | 1.21B | 1.10% | 853,701 | 266.14M |
| 143 | IVA | Inventiva S.A. | 1.19B | -3.16% | 402,191 | 19.93M |
| 144 | SANA | Sana Biotechnology, Inc. | 1.18B | -3.59% | 1,303,882 | - |
| 145 | DAWN | Day One Biopharmaceuticals, Inc. | 1.15B | - | 1,042,076 | 133.67M |
| 146 | CAPR | Capricor Therapeutics, Inc. | 1.15B | -2.08% | 579,571 | 11.13M |
| 147 | EYPT | EyePoint, Inc. | 1.13B | -7.25% | 860,652 | 42.34M |
| 148 | CMPX | Compass Therapeutics, Inc. | 1.13B | -0.47% | 2,023,604 | 850.00K |
| 149 | MLTX | MoonLake Immunotherapeutics | 1.12B | -3.33% | 861,942 | - |
| 150 | INBX | Inhibrx Biosciences, Inc. | 1.11B | 4.87% | 221,601 | 1.40M |
| 151 | ABCL | AbCellera Biologics Inc. | 1.08B | -6.74% | 3,639,399 | 35.33M |
| 152 | PHAT | Phathom Pharmaceuticals, Inc. | 1.07B | 1.11% | 603,333 | 147.19M |
| 153 | AKTS | Aktis Oncology, Inc. | 1.06B | 2.60% | 139,490 | 5.56M |
| 154 | SEPN | Septerna, Inc. | 1.05B | -1.43% | 183,593 | 22.05M |
| 155 | VIR | Vir Biotechnology, Inc. | 1.04B | -3.60% | 1,251,747 | 16.86M |
| 156 | NBTX | Nanobiotix S.A. | 1.04B | -6.30% | 10,665 | 11.93M |
| 157 | ZBIO | Zenas BioPharma, Inc. | 1.02B | -9.00% | 251,537 | 15.00M |
| 158 | IOVA | Iovance Biotherapeutics, Inc. | 1.02B | -2.47% | 6,483,525 | 250.43M |
| 159 | VTYX | Ventyx Biosciences, Inc. | 1.00B | 0.04% | 845,771 | - |
| 160 | ORIC | ORIC Pharmaceuticals, Inc. | 1.00B | -4.46% | 913,671 | - |
| 161 | SPRY | ARS Pharmaceuticals, Inc. | 996.39M | -1.37% | 1,046,494 | 142.77M |
| 162 | GHRS | GH Research PLC | 967.66M | -3.94% | 91,975 | - |
| 163 | TBPH | Theravance Biopharma, Inc. | 964.80M | -0.73% | 207,975 | 80.33M |
| 164 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 959.46M | -4.04% | 102,925 | - |
| 165 | CTMX | CytomX Therapeutics, Inc. | 957.31M | -1.57% | 1,450,578 | 113.63M |
| 166 | AVBP | ArriVent BioPharma, Inc. | 935.85M | 0.76% | 357,127 | - |
| 167 | ANNX | Annexon, Inc. | 925.64M | -4.75% | 1,181,127 | - |
| 168 | URGN | UroGen Pharma Ltd. | 924.01M | -4.59% | 438,396 | 96.52M |
| 169 | BCAX | Bicara Therapeutics Inc. | 922.25M | -0.44% | 176,835 | - |
| 170 | PVLA | Palvella Therapeutics, Inc. | 913.42M | -5.78% | 402,281 | - |
| 171 | ARVN | Arvinas, Inc. | 867.67M | 0.97% | 615,506 | 312.30M |
| 172 | XNCR | Xencor, Inc. | 863.35M | -2.34% | 303,166 | 150.13M |
| 173 | MRVI | Maravai LifeSciences Holdings, Inc. | 861.73M | -1.75% | 910,064 | 192.44M |
| 174 | GERN | Geron Corporation | 858.59M | -1.82% | 7,634,509 | 183.40M |
| 175 | YDES | YD Bio Limited | 829.07M | 6.89% | 32,114 | 510.36K |
| 176 | VALN | Valneva SE | 825.59M | -3.83% | 2,863 | 211.09M |
| 177 | OMER | Omeros Corporation | 824.57M | -2.68% | 854,161 | - |
| 178 | JANX | Janux Therapeutics, Inc. | 819.21M | -1.52% | 681,868 | 10.00M |
| 179 | DRUG | Bright Minds Biosciences Inc. | 804.30M | -5.43% | 82,308 | - |
| 180 | ABUS | Arbutus Biopharma Corporation | 796.22M | 0.24% | 417,458 | 14.61M |
| 181 | KALV | KalVista Pharmaceuticals, Inc. | 796.10M | 0.64% | 287,570 | 1.43M |
| 182 | MPLT | MapLight Therapeutics, Inc. | 779.44M | -3.88% | 141,251 | - |
| 183 | MDXG | MiMedx Group, Inc. | 757.54M | -0.49% | 519,892 | 393.44M |
| 184 | NKTR | Nektar Therapeutics | 751.21M | 4.83% | 786,110 | 62.60M |
| 185 | GYRE | Gyre Therapeutics, Inc. | 731.67M | -1.95% | 69,966 | 107.27M |
| 186 | KURA | Kura Oncology, Inc. | 714.41M | -0.12% | 908,448 | 104.03M |
| 187 | FULC | Fulcrum Therapeutics, Inc. | 707.86M | -1.92% | 234,853 | 80.00M |
| 188 | CGEM | Cullinan Therapeutics, Inc. | 707.14M | 0.42% | 536,069 | - |
| 189 | JBIO | Jade Biosciences, Inc. | 702.48M | -0.72% | 368,023 | - |
| 190 | PRME | Prime Medicine, Inc. | 675.40M | -8.07% | 2,897,351 | 5.98M |
| 191 | SLS | SELLAS Life Sciences Group, Inc. | 642.81M | -2.96% | 4,560,442 | - |
| 192 | ENGN | enGene Holdings Inc. | 639.59M | -7.03% | 256,967 | - |
| 193 | RIGL | Rigel Pharmaceuticals, Inc. | 634.75M | -0.54% | 172,417 | 282.08M |
| 194 | MGTX | MeiraGTx Holdings plc | 612.54M | -1.68% | 213,371 | 27.42M |
| 195 | ALT | Altimmune, Inc. | 611.81M | 9.90% | 4,826,310 | 20.00K |
| 196 | CRMD | CorMedix Inc. | 611.40M | -3.24% | 1,760,739 | 214.30M |
| 197 | PROK | ProKidney Corp. | 607.69M | -5.16% | 941,055 | 744.00K |
| 198 | DSGN | Design Therapeutics, Inc. | 588.15M | -2.32% | 128,349 | - |
| 199 | EVMN | Evommune, Inc. | 580.67M | -14.92% | 465,040 | 13.00M |
| 200 | DRTS | Alpha Tau Medical Ltd. | 578.94M | -6.22% | 275,366 | - |
| 201 | RGNX | REGENXBIO Inc. | 568.50M | -3.19% | 671,889 | 161.32M |
| 202 | REPL | Replimune Group, Inc. | 549.10M | -5.28% | 678,583 | - |
| 203 | KROS | Keros Therapeutics, Inc. | 543.51M | -0.83% | 134,988 | 246.72M |
| 204 | LBRX | LB Pharmaceuticals Inc | 541.27M | 1.06% | 86,259 | - |
| 205 | LXEO | Lexeo Therapeutics, Inc. | 535.00M | -3.17% | 460,005 | - |
| 206 | GOSS | Gossamer Bio, Inc. | 533.51M | -4.75% | 3,578,140 | 44.05M |
| 207 | LYEL | Lyell Immunopharma, Inc. | 518.25M | -1.67% | 60,551 | 41.00K |
| 208 | CTNM | Contineum Therapeutics, Inc. | 515.07M | -3.42% | 406,934 | - |
| 209 | FBRX | Forte Biosciences, Inc. | 513.55M | -1.44% | 168,965 | - |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 513.23M | -3.01% | 473,973 | 180.61M |
| 211 | VOR | Vor Biopharma Inc. | 511.88M | -5.50% | 801,324 | - |
| 212 | FDMT | 4D Molecular Therapeutics, Inc. | 507.36M | -1.00% | 820,154 | 120.00K |
| 213 | ZVRA | Zevra Therapeutics, Inc. | 506.68M | 1.58% | 485,270 | 84.39M |
| 214 | TENX | Tenax Therapeutics, Inc. | 503.88M | -7.11% | 244,934 | - |
| 215 | SLDB | Solid Biosciences Inc. | 503.30M | -2.12% | 614,487 | - |
| 216 | IVVD | Invivyd, Inc. | 494.89M | -5.14% | 2,712,533 | 50.04M |
| 217 | LENZ | LENZ Therapeutics, Inc. | 494.85M | -11.05% | 1,228,330 | 17.50M |
| 218 | NAGE | Niagen Bioscience, Inc. | 485.74M | 1.25% | 334,285 | 124.71M |
| 219 | ANRO | Alto Neuroscience, Inc. | 484.48M | 1.80% | 155,714 | - |
| 220 | OCGN | Ocugen, Inc. | 477.08M | -4.28% | 3,856,517 | 5.37M |
| 221 | VSTM | Verastem, Inc. | 475.05M | -3.98% | 758,543 | 13.38M |
| 222 | PRTA | Prothena Corporation plc | 471.01M | -3.42% | 204,043 | 11.79M |
| 223 | KYTX | Kyverna Therapeutics, Inc. | 455.89M | -2.80% | 1,000,153 | - |
| 224 | ADCT | ADC Therapeutics SA | 454.63M | -2.39% | 540,269 | 75.21M |
| 225 | BCYC | Bicycle Therapeutics plc | 446.04M | -1.38% | 340,621 | 28.34M |
| 226 | ABSI | Absci Corporation | 445.10M | -2.31% | 2,606,630 | 2.82M |
| 227 | VNDA | Vanda Pharmaceuticals Inc. | 443.52M | -3.53% | 561,488 | 212.07M |
| 228 | VTVT | vTv Therapeutics Inc. | 440.14M | 3.87% | 23,791 | 17.00K |
| 229 | PRTC | PureTech Health plc | 439.00M | -2.20% | 1,374 | 6.39M |
| 230 | AVXL | Anavex Life Sciences Corp. | 430.66M | -1.83% | 1,257,233 | - |
| 231 | DMAC | DiaMedica Therapeutics Inc. | 427.02M | -5.90% | 123,333 | - |
| 232 | EPRX | Eupraxia Pharmaceuticals Inc. | 424.68M | -0.24% | 153,470 | - |
| 233 | LXRX | Lexicon Pharmaceuticals, Inc. | 419.73M | -19.79% | 15,250,991 | 70.86M |
| 234 | GLSI | Greenwich LifeSciences, Inc. | 417.58M | 0.40% | 291,385 | - |
| 235 | BNTC | Benitec Biopharma Inc. | 415.15M | -2.78% | 160,727 | - |
| 236 | ALLO | Allogene Therapeutics, Inc. | 411.26M | 15.09% | 14,684,258 | 22.00K |
| 237 | ASMB | Assembly Biosciences, Inc. | 409.35M | 0.66% | 67,201 | 37.19M |
| 238 | MNPR | Monopar Therapeutics Inc. | 407.50M | -9.44% | 260,695 | - |
| 239 | TRDA | Entrada Therapeutics, Inc. | 407.39M | -2.57% | 107,497 | 61.52M |
| 240 | IMMP | Immutep Limited | 407.33M | -7.74% | 343,082 | 3.31M |
| 241 | ACRS | Aclaris Therapeutics, Inc. | 379.75M | 2.19% | 845,563 | 15.74M |
| 242 | TARA | Protara Therapeutics, Inc. | 377.79M | 0.71% | 856,051 | - |
| 243 | NBP | NovaBridge Biosciences | 375.85M | -11.41% | 543,662 | - |
| 244 | RCKT | Rocket Pharmaceuticals, Inc. | 375.53M | -2.25% | 1,255,232 | - |
| 245 | TECX | Tectonic Therapeutic, Inc. | 373.76M | -3.48% | 167,929 | - |
| 246 | ANL | Adlai Nortye Ltd. | 370.48M | 53.75% | 7,057,476 | -1.35M |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 369.73M | -0.70% | 117,476 | 65.32M |
| 248 | ZURA | Zura Bio Limited | 366.08M | -6.63% | 526,050 | - |
| 249 | AUTL | Autolus Therapeutics plc | 365.95M | -3.85% | 1,705,533 | 51.13M |
| 250 | LCTX | Lineage Cell Therapeutics, Inc. | 357.43M | -6.05% | 2,569,475 | 10.82M |
| 251 | AURA | Aura Biosciences, Inc. | 356.57M | 2.46% | 117,318 | - |
| 252 | PEPG | PepGen Inc. | 356.12M | -0.77% | 417,152 | - |
| 253 | NMRA | Neumora Therapeutics, Inc. | 336.48M | -3.41% | 474,190 | - |
| 254 | AVIR | Atea Pharmaceuticals, Inc. | 333.60M | 9.21% | 883,064 | - |
| 255 | FHTX | Foghorn Therapeutics Inc. | 331.57M | -1.91% | 84,444 | 24.52M |
| 256 | HELP | Cybin Inc. | 330.36M | -2.22% | 360,271 | - |
| 257 | PBYI | Puma Biotechnology, Inc. | 325.02M | 0.31% | 181,668 | 212.00M |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 323.95M | 0.41% | 208,054 | 33.98M |
| 259 | ALDX | Aldeyra Therapeutics, Inc. | 320.67M | 0.19% | 556,065 | - |
| 260 | CADL | Candel Therapeutics, Inc. | 319.51M | -1.85% | 399,893 | - |
| 261 | ACIU | AC Immune SA | 315.63M | -6.18% | 194,923 | 5.48M |
| 262 | XOMA | XOMA Royalty Corporation | 312.92M | 1.20% | 138,566 | 47.11M |
| 263 | RZLT | Rezolute, Inc. | 306.93M | 1.85% | 1,436,103 | - |
| 264 | IMMX | Immix Biopharma, Inc. | 305.63M | -2.52% | 717,160 | - |
| 265 | IMRX | Immuneering Corporation | 304.77M | -3.08% | 805,929 | - |
| 266 | LRMR | Larimar Therapeutics, Inc. | 298.28M | -2.38% | 568,320 | - |
| 267 | AARD | Aardvark Therapeutics, Inc. | 283.71M | -2.40% | 137,322 | - |
| 268 | CLLS | Cellectis S.A. | 279.26M | -4.76% | 23,853 | 82.55M |
| 269 | ABEO | Abeona Therapeutics Inc. | 276.38M | 0.39% | 461,660 | 400.00K |
| 270 | AVTX | Avalo Therapeutics, Inc. | 274.17M | -2.89% | 487,280 | 192.00K |
| 271 | NGNE | Neurogene Inc. | 273.39M | -6.56% | 112,400 | 925.00K |
| 272 | RLMD | Relmada Therapeutics, Inc. | 264.73M | -7.67% | 288,182 | - |
| 273 | CHRS | Coherus Oncology, Inc. | 259.87M | -7.73% | 1,533,547 | 277.73M |
| 274 | OABI | OmniAb, Inc. | 258.40M | -3.49% | 386,423 | 21.09M |
| 275 | FENC | Fennec Pharmaceuticals Inc. | 256.32M | -0.20% | 92,619 | 38.79M |
| 276 | ARMP | Armata Pharmaceuticals, Inc. | 253.03M | 4.67% | 45,766 | 5.05M |
| 277 | STTK | Shattuck Labs, Inc. | 248.06M | -3.69% | 458,662 | 1.00M |
| 278 | CABA | Cabaletta Bio, Inc. | 246.44M | -6.91% | 2,135,063 | - |
| 279 | NAUT | Nautilus Biotechnology, Inc. | 246.29M | 0.52% | 113,699 | - |
| 280 | CNTX | Context Therapeutics Inc. | 242.56M | 6.88% | 3,679,097 | - |
| 281 | HRTX | Heron Therapeutics, Inc. | 241.12M | -1.87% | 485,400 | 155.10M |
| 282 | NBY | NovaBay Pharmaceuticals, Inc. | 240.99M | 3.24% | 1,192,606 | 10.30M |
| 283 | ENLV | Enlivex Therapeutics Ltd. | 240.94M | -2.40% | 319,927 | - |
| 284 | MDWD | MediWound Ltd. | 232.71M | 3.07% | 103,384 | 20.93M |
| 285 | SLN | Silence Therapeutics plc | 226.72M | -3.23% | 88,115 | 25.83M |
| 286 | PALI | Palisade Bio, Inc. | 226.48M | -5.59% | 5,909,673 | - |
| 287 | ACHV | Achieve Life Sciences, Inc. | 225.18M | -2.53% | 555,752 | - |
| 288 | VYGR | Voyager Therapeutics, Inc. | 215.17M | -2.76% | 875,323 | 31.32M |
| 289 | CLYM | Climb Bio, Inc. | 214.85M | -5.86% | 375,480 | - |
| 290 | TNXP | Tonix Pharmaceuticals Holding Corp. | 211.28M | -6.42% | 440,097 | 10.30M |
| 291 | ARCT | Arcturus Therapeutics Holdings Inc. | 210.55M | -2.11% | 312,896 | 97.60M |
| 292 | IKT | Inhibikase Therapeutics, Inc. | 208.59M | -2.87% | 536,996 | 1.00 |
| 293 | SABS | SAB Biotherapeutics, Inc. | 206.38M | -1.92% | 93,770 | 114.70K |
| 294 | NVCT | Nuvectis Pharma, Inc. | 204.53M | -6.28% | 104,176 | - |
| 295 | OVID | Ovid Therapeutics Inc. | 202.44M | 0.32% | 1,344,596 | 6.61M |
| 296 | ALEC | Alector, Inc. | 201.93M | -3.14% | 908,077 | 69.05M |
| 297 | CAMP | Camp4 Therapeutics Corporation | 200.26M | -0.26% | 33,165 | 3.80M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 197.63M | -6.17% | 383,076 | 2.82M |
| 299 | MIST | Milestone Pharmaceuticals Inc. | 195.04M | 1.59% | 1,698,082 | - |
| 300 | EDIT | Editas Medicine, Inc. | 192.31M | -4.37% | 1,511,653 | 46.38M |
| 301 | HUMA | Humacyte, Inc. | 191.63M | -3.60% | 2,630,546 | 1.57M |
| 302 | TLSA | Tiziana Life Sciences Ltd | 191.44M | -6.25% | 254,606 | - |
| 303 | CBIO | Crescent Biopharma, Inc. | 189.44M | -4.48% | 158,235 | - |
| 304 | PLX | Protalix BioTherapeutics, Inc. | 188.19M | 13.04% | 2,779,384 | 61.84M |
| 305 | THAR | Tharimmune, Inc. | 187.96M | 6.38% | 3,035,451 | - |
| 306 | SGMT | Sagimet Biosciences Inc. | 184.72M | 5.97% | 917,919 | - |
| 307 | SRZN | Surrozen, Inc. | 184.71M | -2.40% | 63,879 | 3.60M |
| 308 | CCCC | C4 Therapeutics, Inc. | 184.14M | -3.06% | 1,507,449 | 30.11M |
| 309 | MENS | Jyong Biotech Ltd. | 182.25M | -7.42% | 333,915 | - |
| 310 | GALT | Galectin Therapeutics Inc. | 180.52M | -4.44% | 204,453 | - |
| 311 | NERV | Minerva Neurosciences, Inc. | 178.72M | -1.67% | 29,136 | - |
| 312 | RNAC | Cartesian Therapeutics, Inc. | 177.47M | -2.22% | 65,327 | 1.09M |
| 313 | NTHI | NeOnc Technologies Holdings, Inc. | 175.95M | 3.26% | 262,964 | 59.99K |
| 314 | SLGL | Sol-Gel Technologies Ltd. | 174.81M | 3.12% | 58,404 | 18.97M |
| 315 | KLRS | Kalaris Therapeutics, Inc. | 174.49M | 1.41% | 20,879 | - |
| 316 | IPHA | Innate Pharma S.A. | 173.74M | 5.01% | 83,996 | 14.84M |
| 317 | SGMO | Sangamo Therapeutics, Inc. | 173.70M | 0.62% | 8,469,546 | 32.88M |
| 318 | ELDN | Eledon Pharmaceuticals, Inc. | 172.99M | 1.40% | 347,692 | - |
| 319 | CGEN | Compugen Ltd. | 171.64M | -4.92% | 128,198 | 6.90M |
| 320 | PRQR | ProQR Therapeutics N.V. | 170.66M | 1.25% | 358,991 | 18.86M |
| 321 | TNYA | Tenaya Therapeutics, Inc. | 167.79M | -1.90% | 3,159,145 | - |
| 322 | IPSC | Century Therapeutics, Inc. | 166.33M | -5.22% | 1,312,673 | 113.34M |
| 323 | IRD | Opus Genetics, Inc. | 157.93M | -8.40% | 806,603 | 14.63M |
| 324 | MOLN | Molecular Partners AG | 157.11M | -1.39% | 1,124 | 856.30K |
| 325 | NKTX | Nkarta, Inc. | 156.26M | -9.47% | 1,231,639 | - |
| 326 | ZNTL | Zentalis Pharmaceuticals, Inc. | 155.73M | -4.18% | 393,479 | 26.87M |
| 327 | ABOS | Acumen Pharmaceuticals, Inc. | 155.07M | -8.24% | 582,137 | - |
| 328 | PRLD | Prelude Therapeutics Incorporated | 153.26M | -2.11% | 109,780 | 10.50M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 152.12M | -4.87% | 83,948 | - |
| 330 | RANI | Rani Therapeutics Holdings, Inc. | 146.43M | -5.86% | 1,121,786 | 1.20M |
| 331 | BDTX | Black Diamond Therapeutics, Inc. | 140.16M | -6.46% | 614,372 | 70.00M |
| 332 | CNTB | Connect Biopharma Holdings Limited | 138.36M | -2.94% | 68,665 | 762.00K |
| 333 | FATE | Fate Therapeutics, Inc. | 134.96M | -1.68% | 1,233,659 | 7.14M |
| 334 | MCRB | Seres Therapeutics, Inc. | 133.16M | -3.66% | 38,713 | 351.00K |
| 335 | ORMP | Oramed Pharmaceuticals Inc. | 132.71M | -2.51% | 107,825 | 2.00M |
| 336 | VXRT | Vaxart, Inc. | 131.21M | -10.22% | 881,750 | 148.20M |
| 337 | CRBU | Caribou Biosciences, Inc. | 130.86M | -5.41% | 614,782 | 9.30M |
| 338 | ELTX | Elicio Therapeutics, Inc. | 130.28M | -7.74% | 88,540 | - |
| 339 | ADAG | Adagene Inc. | 129.85M | -5.33% | 152,027 | 103.20K |
| 340 | UNCY | Unicycive Therapeutics, Inc. | 128.52M | -10.34% | 1,657,891 | - |
| 341 | WHWK | Whitehawk Therapeutics, Inc. | 127.72M | 0.74% | 45,712 | 14.38M |
| 342 | STRO | Sutro Biopharma, Inc. | 127.71M | 0.47% | 79,841 | 105.65M |
| 343 | KRRO | Korro Bio, Inc. | 125.82M | 0.38% | 287,507 | 7.37M |
| 344 | SPRO | Spero Therapeutics, Inc. | 123.38M | -2.67% | 215,298 | 40.55M |
| 345 | KPTI | Karyopharm Therapeutics Inc. | 118.83M | -2.11% | 192,549 | 142.53M |
| 346 | TTRX | Turn Therapeutics Inc. | 118.52M | -7.47% | 49,716 | - |
| 347 | GNLX | Genelux Corporation | 118.24M | -2.55% | 113,030 | 8.00K |
| 348 | CRDF | Cardiff Oncology, Inc. | 117.88M | 8.36% | 1,912,190 | 501.00K |
| 349 | ACOG | Alpha Cognition Inc. | 116.75M | 3.67% | 12,015 | 7.43M |
| 350 | MGNX | MacroGenics, Inc. | 115.76M | -5.18% | 844,854 | 127.63M |
| 351 | VRCA | Verrica Pharmaceuticals Inc. | 113.21M | -1.80% | 97,113 | 30.83M |
| 352 | INO | Inovio Pharmaceuticals, Inc. | 111.64M | 0.93% | 837,493 | 182.34K |
| 353 | CDXS | Codexis, Inc. | 111.10M | -5.38% | 731,458 | 52.93M |
| 354 | VANI | Vivani Medical, Inc. | 111.00M | -7.95% | 533,787 | - |
| 355 | ACTU | Actuate Therapeutics, Inc. | 108.31M | -1.69% | 44,721 | - |
| 356 | CBUS | Cibus, Inc. | 107.36M | 3.13% | 425,270 | 3.79M |
| 357 | ONCY | Oncolytics Biotech Inc. | 105.13M | -3.27% | 1,087,681 | - |
| 358 | SEER | Seer, Inc. | 102.66M | -1.88% | 122,279 | 16.38M |
| 359 | CSBR | Champions Oncology, Inc. | 102.48M | -0.54% | 955 | 58.42M |
| 360 | ANIX | Anixa Biosciences, Inc. | 101.13M | -2.26% | 142,995 | - |
| 361 | COYA | Coya Therapeutics, Inc. | 98.14M | 1.96% | 253,383 | 3.99M |
| 362 | CGTX | Cognition Therapeutics, Inc. | 97.98M | -10.48% | 1,835,547 | - |
| 363 | FBIO | Fortress Biotech, Inc. | 97.46M | -6.55% | 709,764 | 62.30M |
| 364 | AGEN | Agenus Inc. | 96.41M | -5.18% | 443,692 | 106.83M |
| 365 | SAVA | Cassava Sciences, Inc. | 95.17M | -3.43% | 691,036 | - |
| 366 | DTIL | Precision BioSciences, Inc. | 94.36M | -1.63% | 196,705 | 698.00K |
| 367 | ARTV | Artiva Biotherapeutics, Inc. | 94.25M | -7.47% | 304,155 | 251.00K |
| 368 | ALXO | ALX Oncology Holdings Inc. | 92.17M | 8.28% | 2,107,366 | - |
| 369 | DWTX | Dogwood Therapeutics, Inc. | 91.43M | -1.73% | 50,711 | - |
| 370 | PYXS | Pyxis Oncology, Inc. | 90.59M | -6.73% | 328,275 | 2.82M |
| 371 | MAIA | MAIA Biotechnology, Inc. | 88.78M | -2.93% | 416,373 | - |
| 372 | EQ | Equillium, Inc. | 86.47M | 2.90% | 957,484 | 4.39M |
| 373 | EXOZ | eXoZymes, Inc. | 86.10M | 0.59% | 3,658 | -700.00 |
| 374 | MNOV | MediciNova, Inc. | 86.01M | - | 53,503 | 257.92K |
| 375 | ATYR | aTyr Pharma, Inc. | 85.22M | 2.25% | 2,617,275 | 190.00K |
| 376 | SPRB | Spruce Biosciences, Inc. | 82.92M | -2.99% | 12,671 | 697.00K |
| 377 | ETHZ | ETHZilla Corporation | 80.42M | -8.84% | 617,593 | 4.11M |
| 378 | ACET | Adicet Bio, Inc. | 80.04M | -6.82% | 156,472 | - |
| 379 | IMA | ImageneBio, Inc. | 79.46M | 1.84% | 83,068 | 800.00K |
| 380 | BMEA | Biomea Fusion, Inc. | 78.83M | -5.51% | 1,014,814 | - |
| 381 | COEP | Coeptis Therapeutics Holdings, Inc. | 78.53M | 1.58% | 38,325 | 501.00K |
| 382 | PTHS | Pelthos Therapeutics Inc. | 76.98M | -3.26% | 7,268 | 7.41M |
| 383 | XBIT | XBiotech Inc. | 76.98M | -0.59% | 6,336 | - |
| 384 | OKYO | OKYO Pharma Limited | 76.05M | -0.89% | 270,592 | - |
| 385 | PYPD | PolyPid Ltd. | 76.02M | -2.97% | 33,249 | - |
| 386 | HYFT | MindWalk Holdings Corp. | 75.17M | -10.56% | 795,323 | 19.02M |
| 387 | IMUX | Immunic, Inc. | 74.77M | 1.90% | 932,249 | - |
| 388 | PLRX | Pliant Therapeutics, Inc. | 73.74M | -3.23% | 996,762 | - |
| 389 | GUTS | Fractyl Health, Inc. | 73.56M | -18.00% | 35,057,036 | 3.00K |
| 390 | MREO | Mereo BioPharma Group plc | 72.83M | 4.02% | 6,028,549 | 500.00K |
| 391 | ATOS | Atossa Therapeutics, Inc. | 72.67M | -6.23% | 2,594,133 | - |
| 392 | GANX | Gain Therapeutics, Inc. | 70.39M | -4.69% | 432,199 | - |
| 393 | ANVS | Annovis Bio, Inc. | 69.57M | -6.58% | 430,840 | - |
| 394 | BYSI | BeyondSpring Inc. | 65.38M | 1.92% | 14,670 | 1.88M |
| 395 | ENTX | Entera Bio Ltd. | 64.20M | -4.11% | 111,819 | 124.00K |
| 396 | TVGN | Tevogen Bio Holdings Inc. | 63.20M | 5.13% | 3,406,088 | - |
| 397 | NRXP | NRx Pharmaceuticals, Inc. | 62.61M | -0.24% | 298,440 | 242.00K |
| 398 | KZIA | Kazia Therapeutics Limited | 62.11M | -6.56% | 273,244 | 1.20M |
| 399 | IFRX | InflaRx N.V. | 60.29M | -3.54% | 196,299 | 73.73K |
| 400 | TCRX | TScan Therapeutics, Inc. | 58.45M | -0.96% | 450,085 | 8.42M |
| 401 | PMVP | PMV Pharmaceuticals, Inc. | 58.00M | -2.68% | 150,558 | - |
| 402 | NTRB | Nutriband Inc. | 57.56M | 4.76% | 9,890 | 2.28M |
| 403 | MGX | Metagenomi Therapeutics, Inc. | 57.45M | -3.16% | 163,630 | 30.91M |
| 404 | ACRV | Acrivon Therapeutics, Inc. | 56.80M | -4.26% | 541,674 | - |
| 405 | INKT | MiNK Therapeutics, Inc. | 56.00M | -2.57% | 18,703 | - |
| 406 | GRCE | Grace Therapeutics, Inc. | 55.71M | 2.56% | 68,184 | - |
| 407 | ICCC | ImmuCell Corporation | 55.50M | 1.57% | 5,967 | 27.77M |
| 408 | ATHE | Alterity Therapeutics Limited | 53.24M | -2.76% | 12,147 | 3.57M |
| 409 | RADX | Radiopharm Theranostics Limited | 52.08M | -0.90% | 32,480 | 8.20M |
| 410 | IBO | Impact BioMedical Inc. | 51.26M | 2.94% | 68,533 | 25.00K |
| 411 | ALGS | Aligos Therapeutics, Inc. | 49.84M | -0.18% | 36,040 | 2.65M |
| 412 | LPCN | Lipocine Inc. | 49.75M | -0.33% | 80,154 | 4.32M |
| 413 | OSTX | OS Therapies Incorporated | 49.48M | 1.81% | 380,732 | - |
| 414 | QTTB | Q32 Bio Inc. | 48.85M | -1.24% | 166,237 | - |
| 415 | CVM | CEL-SCI Corporation | 48.69M | -1.36% | 66,799 | - |
| 416 | TIL | Instil Bio, Inc. | 48.22M | -1.25% | 25,919 | - |
| 417 | ABVC | ABVC BioPharma, Inc. | 48.08M | -1.92% | 47,544 | 797.92K |
| 418 | IBIO | iBio, Inc. | 47.00M | -2.79% | 846,517 | 500.00K |
| 419 | CRVO | CervoMed Inc. | 46.87M | -2.03% | 70,252 | 6.16M |
| 420 | NRXS | NeurAxis, Inc. | 46.55M | -6.02% | 116,736 | 3.36M |
| 421 | ESLA | Estrella Immunopharma, Inc. | 45.82M | 0.93% | 55,067 | - |
| 422 | PDSB | PDS Biotechnology Corporation | 45.42M | -4.82% | 367,651 | - |
| 423 | KZR | Kezar Life Sciences, Inc. | 44.85M | -0.73% | 25,143 | - |
| 424 | LONA | LeonaBio, Inc. | 44.72M | 1.70% | 43,380 | - |
| 425 | LITS | Lite Strategy, Inc. | 44.12M | -4.00% | 239,529 | - |
| 426 | ANEB | Anebulo Pharmaceuticals, Inc. | 44.07M | 22.58% | 152,525 | - |
| 427 | INMB | INmune Bio Inc. | 41.87M | 0.96% | 132,097 | 50.00K |
| 428 | JSPR | Jasper Therapeutics, Inc. | 41.14M | -5.16% | 319,854 | - |
| 429 | CING | Cingulate Inc. | 41.02M | -0.17% | 175,862 | - |
| 430 | VERU | Veru Inc. | 40.77M | -2.68% | 63,522 | 16.89M |
| 431 | APLM | Apollomics, Inc. | 40.71M | 5.86% | 2,807 | 6.93M |
| 432 | PSTV | Plus Therapeutics, Inc. | 40.71M | -6.12% | 9,470,727 | 5.26M |
| 433 | LSTA | Lisata Therapeutics, Inc. | 40.49M | -1.08% | 71,660 | 1.07M |
| 434 | XLO | Xilio Therapeutics, Inc. | 40.02M | -2.84% | 409,964 | 31.80M |
| 435 | GLTO | Galecto, Inc. | 40.02M | -0.18% | 35,301 | - |
| 436 | TELO | Telomir Pharmaceuticals, Inc. | 39.54M | -5.74% | 451,178 | - |
| 437 | NXTC | NextCure, Inc. | 38.61M | 5.71% | 27,901 | - |
| 438 | GBIO | Generation Bio Co. | 37.73M | -0.36% | 69,983 | 15.27M |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 37.59M | -2.03% | 65,815 | 90.00K |
| 440 | PASG | Passage Bio, Inc. | 37.29M | 9.32% | 41,665 | - |
| 441 | ATRA | Atara Biotherapeutics, Inc. | 37.28M | -6.17% | 164,302 | 151.93M |
| 442 | TVRD | Tvardi Therapeutics, Inc. | 37.06M | 1.28% | 44,248 | - |
| 443 | RNXT | RenovoRx, Inc. | 37.02M | 5.21% | 273,811 | 928.00K |
| 444 | OKUR | OnKure Therapeutics, Inc. | 36.58M | -1.10% | 65,043 | - |
| 445 | LTRN | Lantern Pharma Inc. | 35.01M | 0.64% | 88,909 | - |
| 446 | SER | Serina Therapeutics, Inc. | 34.76M | -7.91% | 1,552,847 | 116.00K |
| 447 | CELU | Celularity Inc. | 34.61M | -5.29% | 43,854 | 40.58M |
| 448 | RNTX | Rein Therapeutics Inc. | 33.91M | -9.79% | 130,347 | - |
| 449 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 33.57M | -3.82% | 1,812,022 | - |
| 450 | LIXT | Lixte Biotechnology Holdings, Inc. | 33.19M | -2.56% | 161,237 | - |
| 451 | PLUR | Pluri Inc. | 33.18M | 0.15% | 7,264 | 1.33M |
| 452 | DYAI | Dyadic International, Inc. | 32.93M | 0.55% | 37,385 | 3.34M |
| 453 | HURA | TuHURA Biosciences, Inc. | 32.55M | -4.46% | 253,428 | - |
| 454 | SKYE | Skye Bioscience, Inc. | 32.38M | 5.21% | 146,660 | - |
| 455 | KYNB | Kyntra Bio, Inc. | 32.16M | -0.75% | 46,345 | 8.30M |
| 456 | HOWL | Werewolf Therapeutics, Inc. | 32.08M | -8.79% | 386,439 | 1.14M |
| 457 | OTLK | Outlook Therapeutics, Inc. | 32.01M | -5.33% | 1,371,276 | 1.41M |
| 458 | ANTX | AN2 Therapeutics, Inc. | 31.79M | 2.65% | 14,701 | - |
| 459 | PMN | ProMIS Neurosciences, Inc. | 30.78M | 19.12% | 7,807,123 | - |
| 460 | CUE | Cue Biopharma, Inc. | 30.08M | -8.75% | 682,816 | 7.10M |
| 461 | HYPD | Hyperion DeFi, Inc. | 29.48M | -4.10% | 202,762 | 345.32K |
| 462 | BRNS | Barinthus Biotherapeutics plc | 29.10M | -1.19% | 2,617 | 14.97M |
| 463 | RLYB | Rallybio Corporation | 29.00M | 2.80% | 170,777 | 674.00K |
| 464 | AEON | AEON Biopharma, Inc. | 28.83M | 0.84% | 80,437 | - |
| 465 | NRSN | NeuroSense Therapeutics Ltd. | 27.40M | -2.87% | 141,189 | - |
| 466 | MRKR | Marker Therapeutics, Inc. | 27.34M | 1.86% | 116,885 | 4.69M |
| 467 | PTN | Palatin Technologies, Inc. | 26.97M | 0.73% | 17,956 | 8.85M |
| 468 | BCTX | BriaCell Therapeutics Corp. | 26.89M | -1.16% | 207,554 | - |
| 469 | SNTI | Senti Biosciences, Inc. | 26.69M | -0.49% | 145,928 | - |
| 470 | EVAX | Evaxion A/S | 26.52M | -6.47% | 62,021 | 7.65M |
| 471 | XCUR | Exicure, Inc. | 26.36M | -2.93% | 11,287 | 500.00K |
| 472 | DARE | Daré Bioscience, Inc. | 26.29M | -3.16% | 177,374 | -57.13K |
| 473 | IGC | IGC Pharma, Inc. | 26.27M | -1.12% | 331,306 | 1.11M |
| 474 | BOLD | Boundless Bio, Inc. | 25.74M | -2.54% | 108,263 | - |
| 475 | CLGN | CollPlant Biotechnologies Ltd. | 24.02M | -1.36% | 13,402 | 2.48M |
| 476 | GNTA | Genenta Science S.p.A. | 23.43M | -14.53% | 260,945 | - |
| 477 | FBLG | FibroBiologics, Inc. | 22.39M | -1.35% | 424,624 | - |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 22.20M | 3.84% | 551,877 | 721.00K |
| 479 | INTS | Intensity Therapeutics, Inc. | 22.06M | -2.11% | 835,803 | - |
| 480 | NEUP | Neuphoria Therapeutics Inc. | 21.51M | -0.50% | 18,749 | 15.65M |
| 481 | IOBT | IO Biotech, Inc. | 21.38M | -6.04% | 1,292,805 | - |
| 482 | NNVC | NanoViricides, Inc. | 20.92M | -2.99% | 174,038 | - |
| 483 | CASI | CASI Pharmaceuticals, Inc. | 20.34M | -0.01% | 48,906 | 26.85M |
| 484 | KTTA | Pasithea Therapeutics Corp. | 20.32M | 2.33% | 111,021 | - |
| 485 | KLTO | Klotho Neurosciences, Inc. | 19.94M | -2.20% | 1,030,526 | - |
| 486 | LEXX | Lexaria Bioscience Corp. | 19.84M | 5.45% | 130,579 | 522.00K |
| 487 | INAB | IN8bio, Inc. | 19.39M | -0.75% | 30,346 | - |
| 488 | LNAI | Lunai Bioworks Inc. | 18.98M | -3.57% | 24,107 | - |
| 489 | VYNE | VYNE Therapeutics Inc. | 18.84M | -0.07% | 801,579 | 524.00K |
| 490 | QNTM | Quantum BioPharma Ltd. | 18.44M | -6.37% | 37,631 | - |
| 491 | PLRZ | Polyrizon Ltd. | 18.33M | -12.35% | 51,231 | - |
| 492 | ALLR | Allarity Therapeutics, Inc. | 17.80M | -1.91% | 163,267 | - |
| 493 | JUNS | Jupiter Neurosciences, Inc. | 17.47M | -15.42% | 402,064 | - |
| 494 | TRAW | Traws Pharma, Inc. | 17.06M | 1.67% | 143,840 | 2.85M |
| 495 | BCAB | BioAtla, Inc. | 16.47M | -9.90% | 2,132,518 | 11.00M |
| 496 | ITRM | Iterum Therapeutics plc | 16.25M | -1.82% | 240,543 | 390.00K |
| 497 | CVKD | Cadrenal Therapeutics, Inc. | 16.23M | -6.97% | 35,574 | - |
| 498 | OSRH | OSR Holdings, Inc. | 16.05M | -3.10% | 346,901 | -90.52K |
| 499 | APLT | Applied Therapeutics, Inc. | 15.87M | 9.01% | 3,991,990 | 1.00M |
| 500 | CTXR | Citius Pharmaceuticals, Inc. | 15.37M | -3.88% | 198,020 | - |
| 501 | LIMN | Liminatus Pharma, Inc. | 14.89M | -6.83% | 67,512 | - |
| 502 | KALA | KALA BIO, Inc. | 14.69M | -3.70% | 467,844 | - |
| 503 | KAPA | Kairos Pharma, Ltd. | 14.24M | 2.89% | 108,520 | - |
| 504 | COCP | Cocrystal Pharma, Inc. | 13.78M | - | 42,665 | - |
| 505 | HOTH | Hoth Therapeutics, Inc. | 13.52M | -4.73% | 177,669 | - |
| 506 | BLRX | BioLineRx Ltd. | 13.52M | -2.84% | 11,330 | 12.74M |
| 507 | CLRB | Cellectar Biosciences, Inc. | 13.40M | -2.47% | 25,301 | - |
| 508 | TPST | Tempest Therapeutics, Inc. | 13.30M | 92.17% | 78,316 | - |
| 509 | BCDA | BioCardia, Inc. | 13.05M | -2.38% | 52,561 | 3.00K |
| 510 | MBRX | Moleculin Biotech, Inc. | 12.84M | -2.57% | 32,712 | - |
| 511 | CALC | CalciMedica, Inc. | 12.83M | -12.68% | 1,834,796 | - |
| 512 | SNGX | Soligenix, Inc. | 12.51M | -5.34% | 242,536 | 2.34K |
| 513 | BOLT | Bolt Biotherapeutics, Inc. | 12.00M | - | 25,724 | 5.20M |
| 514 | SNSE | Sensei Biotherapeutics, Inc. | 11.91M | -2.28% | 60,473 | - |
| 515 | LGVN | Longeveron Inc. | 11.81M | -4.52% | 128,079 | 1.44M |
| 516 | NCEL | NewcelX Ltd. | 11.67M | 0.39% | 60,212 | - |
| 517 | CRIS | Curis, Inc. | 11.56M | -1.79% | 128,659 | 11.65M |
| 518 | IMNN | Imunon, Inc. | 11.29M | 0.30% | 16,984 | - |
| 519 | PHIO | Phio Pharmaceuticals Corp. | 10.87M | -0.98% | 216,788 | - |
| 520 | AKTX | Akari Therapeutics, Plc | 10.83M | 2.20% | 101,530 | - |
| 521 | GRDX | GridAI Technologies Corp. | 10.49M | 9.47% | 197,785 | - |
| 522 | NCNA | NuCana plc | 10.36M | -8.12% | 74,676 | - |
| 523 | BRTX | BioRestorative Therapies, Inc. | 10.16M | 0.44% | 16,983 | 383.40K |
| 524 | EDSA | Edesa Biotech, Inc. | 9.79M | -4.47% | 271,825 | - |
| 525 | PULM | Pulmatrix, Inc. | 9.72M | 1.53% | 5,406 | 3.00K |
| 526 | CMMB | Chemomab Therapeutics Ltd. | 9.69M | 0.32% | 11,879 | - |
| 527 | ERNA | Ernexa Therapeutics Inc. | 9.58M | 1.67% | 29,835 | 1,000.00 |
| 528 | QNCX | Quince Therapeutics, Inc. | 9.48M | -36.99% | 30,709,374 | - |
| 529 | REVB | Revelation Biosciences, Inc. | 9.44M | 4.69% | 356,080 | - |
| 530 | EVGN | Evogene Ltd. | 9.22M | - | 9,215 | 8.02M |
| 531 | GDTC | CytoMed Therapeutics Limited | 9.13M | -5.99% | 4,451 | 573.19K |
| 532 | RNAZ | TransCode Therapeutics, Inc. | 8.89M | -7.42% | 13,061 | - |
| 533 | BIVI | BioVie Inc. | 8.82M | -5.65% | 95,803 | - |
| 534 | KPRX | Kiora Pharmaceuticals, Inc. | 8.80M | 4.33% | 137,198 | 20.00K |
| 535 | PHGE | BiomX Inc. | 8.70M | -19.15% | 192,909 | - |
| 536 | ICU | SeaStar Medical Holding Corporation | 8.44M | 0.21% | 159,106 | 881.00K |
| 537 | PMCB | PharmaCyte Biotech, Inc. | 8.31M | -3.30% | 206,923 | - |
| 538 | XTLB | XTL Biopharmaceuticals Ltd. | 8.27M | 2.88% | 34,619 | 968.00K |
| 539 | ALZN | Alzamend Neuro, Inc. | 8.21M | 6.93% | 55,077 | - |
| 540 | IMRN | Immuron Limited | 7.97M | -0.64% | 24,079 | 4.78M |
| 541 | APM | Aptorum Group Limited | 7.92M | 19.46% | 145,651 | - |
| 542 | VIVS | VivoSim Labs, Inc. | 7.64M | 72.35% | 69,747,628 | 140.00K |
| 543 | MTVA | MetaVia Inc. | 7.64M | 0.85% | 312,575 | - |
| 544 | ADXN | Addex Therapeutics Ltd | 7.59M | -5.83% | 1,304 | 198.82K |
| 545 | CLDI | Calidi Biotherapeutics, Inc. | 7.39M | -3.81% | 83,024 | - |
| 546 | APVO | Aptevo Therapeutics Inc. | 7.25M | -1.62% | 30,255 | - |
| 547 | MBIO | Mustang Bio, Inc. | 7.08M | -0.11% | 29,001 | - |
| 548 | CELZ | Creative Medical Technology Holdings, Inc. | 7.06M | -4.27% | 27,476 | 6.00K |
| 549 | GTBP | GT Biopharma, Inc. | 7.02M | -2.93% | 472,088 | - |
| 550 | PCSA | Processa Pharmaceuticals, Inc. | 6.76M | -4.94% | 28,491 | - |
| 551 | PPBT | Purple Biotech Ltd | 6.62M | -4.62% | 64,951 | - |
| 552 | TOVX | Theriva Biologics, Inc. | 6.33M | -4.83% | 1,710,237 | - |
| 553 | GNPX | Genprex, Inc. | 6.16M | 7.93% | 1,800,758 | - |
| 554 | TCRT | Alaunos Therapeutics, Inc. | 6.09M | -0.73% | 36,076 | 6.00K |
| 555 | QNRX | Quoin Pharmaceuticals, Ltd. | 6.04M | -13.25% | 51,095 | - |
| 556 | ADIL | Adial Pharmaceuticals, Inc. | 5.97M | 0.66% | 241,185 | - |
| 557 | CANF | Can-Fite BioPharma Ltd. | 5.94M | -1.22% | 14,215 | 560.00K |
| 558 | SLXN | Silexion Therapeutics Corp | 5.94M | -3.06% | 101,414 | - |
| 559 | BGMS | Bio Green Med Solution, Inc. | 5.93M | -1.63% | 18,984 | 81.00K |
| 560 | ACXP | Acurx Pharmaceuticals, Inc. | 5.61M | -4.21% | 57,130 | - |
| 561 | ASBP | Aspire Biopharma Holdings, Inc. | 5.59M | 42.47% | 5,080,799 | 1.94K |
| 562 | APRE | Aprea Therapeutics, Inc. | 5.53M | 33.90% | 106,973,390 | 488.24K |
| 563 | ABP | Abpro Holdings, Inc. | 5.49M | 3.59% | 32,141 | 183.00K |
| 564 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 5.48M | -11.98% | 167,309 | 1.36M |
| 565 | DRMA | Dermata Therapeutics, Inc. | 5.47M | -18.51% | 914,292 | - |
| 566 | CYCN | Cyclerion Therapeutics, Inc. | 5.25M | 0.73% | 29,377 | 2.86M |
| 567 | XBIO | Xenetic Biosciences, Inc. | 5.09M | -4.72% | 14,841 | 2.86M |
| 568 | INDP | Indaptus Therapeutics, Inc. | 5.02M | 2.28% | 16,292 | - |
| 569 | DCOY | Decoy Therapeutics Inc. | 4.85M | -8.32% | 128,987 | - |
| 570 | GOVX | GeoVax Labs, Inc. | 4.72M | -2.83% | 92,527 | 3.35M |
| 571 | SILO | Silo Pharma, Inc. | 4.69M | 6.96% | 101,512 | 72.10K |
| 572 | MLEC | Moolec Science SA | 4.62M | -1.70% | 157,114 | 7.83M |
| 573 | PBM | Psyence Biomedical Ltd. | 4.11M | -10.69% | 475,124 | - |
| 574 | ELAB | PMGC Holdings Inc. | 4.04M | 2.40% | 711,238 | 285.95K |
| 575 | MTNB | Matinas BioPharma Holdings, Inc. | 3.91M | -8.33% | 54,133 | - |
| 576 | GLMD | Galmed Pharmaceuticals Ltd. | 3.87M | -5.79% | 66,532 | - |
| 577 | CNSP | CNS Pharmaceuticals, Inc. | 3.56M | -0.78% | 31,926 | - |
| 578 | OGEN | Oragenics, Inc. | 3.47M | -1.07% | 39,755 | - |
| 579 | XRTX | XORTX Therapeutics Inc. | 3.45M | 7.12% | 34,975 | - |
| 580 | ARTL | Artelo Biosciences, Inc. | 3.44M | 1.54% | 18,824 | - |
| 581 | SCNI | Scinai Immunotherapeutics Ltd. | 3.40M | 1.03% | 27,455 | 1.15M |
| 582 | SPRC | SciSparc Ltd. | 3.36M | -2.38% | 131,049 | 1.31M |
| 583 | LYRA | Lyra Therapeutics, Inc. | 3.27M | -9.80% | 23,370 | 600.00K |
| 584 | CMND | Clearmind Medicine Inc. | 3.19M | -2.74% | 28,435 | - |
| 585 | JAGX | Jaguar Health, Inc. | 3.12M | -0.45% | 303,674 | 11.79M |
| 586 | HCWB | HCW Biologics Inc. | 3.11M | 0.88% | 71,874 | 422.03K |
| 587 | ENVB | Enveric Biosciences, Inc. | 3.08M | -1.95% | 44,891 | - |
| 588 | PPCB | Propanc Biopharma, Inc. | 2.94M | -20.94% | 1,022,136 | - |
| 589 | BBLG | Bone Biologics Corporation | 2.93M | -2.98% | 20,774 | - |
| 590 | CDIO | Cardio Diagnostics Holdings, Inc. | 2.78M | -4.69% | 75,673 | 15.78K |
| 591 | AZTR | Azitra, Inc. | 2.60M | -8.76% | 1,360,289 | 7.50K |
| 592 | ENSC | Ensysce Biosciences, Inc. | 2.59M | -0.90% | 90,151 | 4.49M |
| 593 | ONCO | Onconetix, Inc. | 2.16M | -6.93% | 46,524 | 1.22M |
| 594 | VRAX | Virax Biolabs Group Limited | 2.01M | -4.84% | 123,604 | 2.99K |
| 595 | CDT | CDT Equity Inc. | 1.88M | -1.82% | 41,697 | - |
| 596 | GRI | GRI Bio, Inc. | 1.74M | -2.41% | 183,190 | - |
| 597 | BDRX | Biodexa Pharmaceuticals Plc | 1.47M | -4.89% | 105,633 | 104.90K |
| 598 | ADTX | Aditxt, Inc. | 1.39M | -4.78% | 123,457 | 5.95K |